| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |